PE-Prove Study PROMUS* Element* Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study A prospective, open label, multi-center observational study
Phase 4
Completed
- Conditions
- Coronary artery diseaseNarrowing of arteries10011082
- Registration Number
- NL-OMON34092
- Lead Sponsor
- Boston Scientific International S.A.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
All patients who are candidates for Coronary artery stenting, signed the Informed Consent Form and are eligible to receive a PROMUS* Element* stent will be evaluated for enrollment in this study.
Exclusion Criteria
No study-specific exclusion criteria apart from any contra-indications
Page 20-21 protocol
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method